Article
[HLA-B*5701 and abacavir hypersensitivity reaction].
Pathologie-biologie - 1 Dec 2010
Servonnet A, Leclercq E, Delacour H, Ceppa F
Abstract excerpt
A potentially life-threatening hypersensitive reaction occurs in association with initiation of HIV nucleoside analogue abacavir therapy in 4 to 8% of patients. Preliminary studies appear to confirm the role of the immune system in abacavir hypersensitivity. The reaction is possibly the result of presentation of drug peptides onto HLA, that may induce a pathogenic T-cell response. Hypersensitivity reaction to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
